SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-112849
Filing Date
2024-10-31
Accepted
2024-10-31 07:07:03
Documents
14
Period of Report
2024-10-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2427193d1_8k.htm   iXBRL 8-K 27985
2 EXHIBIT 99.1 tm2427193d1_ex99-1.htm EX-99.1 22098
  Complete submission text file 0001104659-24-112849.txt   229613

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20241030.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20241030_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20241030_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2427193d1_8k_htm.xml XML 3570
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 241412400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)